Antibodies control metabolism by regulating insulin homeostasis
T. Amendt, G. Allies, A. Nicolo, O. El Ayoubi, M. Young, T. Roeszer, C. S. Setz, K. Warnatz, H. Jumaa
Abstract
Homeostasis of metabolism by hormone production is crucial to maintain physiological integrity and disbalance can cause severe metabolic disorders such as diabetes mellitus. Here, we show that antibodies recognizing insulin are key regulators of blood glucose and metabolism controlling insulin concentrations. In fact, antibody-deficient mice and immunodeficiency patients show sub-physiological blood glucose, which becomes normal after total IgG injection. We show that insulin-specific IgG antibodies found in the serum of wildtype mice or healthy individuals are responsible for this regulation. Interestingly, we identify two fractions of anti-insulin IgM which differ in their affinity to insulin. The low affinity IgM fraction (anti-insulin IgMlow) neutralizes insulin and leads to increased blood glucose while the high affinity IgM fraction (anti-insulin IgMhigh) protects insulin from neutralization by anti-insulin IgG thereby preventing blood glucose dysregulation. In contrast to anti-insulin IgMhigh, anti-insulin IgMlow binds to dsDNA suggesting that it is multi-specific. This multi-specificity mediates the formation of larger immune complexes containing insulin which results in increased uptake and degradation of insulin by macrophages in the presence of anti-insulin IgMlow as compared to anti-insulin IgMhigh. To demonstrate that high affinity anti-insulin IgM acts as protector of insulin and counteracts insulin neutralization by anti-insulin IgG, we expressed the variable regions of the same anti-insulin antibody as IgG or IgM. Strikingly, only the anti-insulin IgM regulated insulin function and prevented IgG-mediated neutralization of insulin and subsequent blood glucose dysregulation. Since anti-insulin IgMhigh is generated in the course of an immune response and affinity maturation, its protective role suggests that preventing autoimmune damage and maintaining physiological homeostasis requires adaptive tolerance mechanisms that generate protective IgM antibodies during memory responses.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Anti-Insulin receptor antibodies improve hyperglycaemia in a mouse model of human insulin receptoropathy
G. V. Brierley, H. Webber, … R. Semple·bioRxiv·Mar 20, 2020
- Insulin-deficient diabetes impairs vaccine-mediated antibody and germinal center B-cell formation in mice
Christopher J. Genito, Pablo Ariel, … Lance R. Thurlow·bioRxiv·Sep 24, 2025
- Evaluation of anti insulin receptor antibodies as potential novel therapies for human insulin receptoropathy
G. Brierley, K. Siddle, R. K. Semple·bioRxiv·Nov 22, 2017
- Targeted neutralizing IgY antibodies against SGLT1 glucose transporter reduce glucose uptake and improve glycemic profile in vivo
U. Saxena, K. Meher, … S. Chandran·bioRxiv·May 6, 2023
- Myeloid Gi signaling acts as a weight-independent immunometabolic switch controlling systemic insulin sensitivity
Seema Kuldeep, H.N. Yadav, … Sai Prasad Pydi·bioRxiv·Mar 31, 2026
- Oral glucose feeding enhances adherence of quiescent lymphocytes to fibronectin via non-canonical insulin signalling.
A. C. T. Mallu, S. Sivagurunathan, … M. Dixit·bioRxiv·Oct 13, 2021